CSL Financials
| CSLLY Stock | USD 83.82 2.99 3.70% |
CSL |
Understanding current and past CSL Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CSL's financial statements are interrelated, with each one affecting the others. For example, an increase in CSL's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CSL's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CSL. Check CSL's Beneish M Score to see the likelihood of CSL's management manipulating its earnings.
CSL Stock Summary
CSL competes with CSL, Pmv Pharmaceuticals, Novo Nordisk, Kalvista Pharmaceuticals, and ProKidney Corp. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US12637N2045 |
| Business Address | 45 Poplar Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.csl.com.au |
| Phone | 61 3 9389 1911 |
| Currency | USD - US Dollar |
CSL Key Financial Ratios
CSL's financial ratios allow both analysts and investors to convert raw data from CSL's financial statements into concise, actionable information that can be used to evaluate the performance of CSL over time and compare it to other companies across industries.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0613 | |||
| Beta | 0.19 | |||
| Z Score | 15.6 | |||
| Last Dividend Paid | 2.22 |
CSL Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSL's current stock value. Our valuation model uses many indicators to compare CSL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSL competition to find correlations between indicators driving CSL's intrinsic value. More Info.CSL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSL is roughly 2.18 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CSL by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CSL's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CSL Systematic Risk
CSL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CSL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on CSL correlated with the market. If Beta is less than 0 CSL generally moves in the opposite direction as compared to the market. If CSL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CSL is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CSL is generally in the same direction as the market. If Beta > 1 CSL moves generally in the same direction as, but more than the movement of the benchmark.
CSL July 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CSL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CSL. We use our internally-developed statistical techniques to arrive at the intrinsic value of CSL based on widely used predictive technical indicators. In general, we focus on analyzing CSL Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CSL's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.55 | |||
| Information Ratio | 0.0044 | |||
| Maximum Drawdown | 6.71 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 2.57 |
Additional Tools for CSL Pink Sheet Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.